BiotechTube
Home/NysnoBio/David M. Weiner, MD
DM

David M. Weiner, MD

Chief Medical Officer

NysnoBio

Therapeutic Areas

Parkinson's DiseaseNeurodegenerative Diseases

NysnoBio Pipeline

DrugIndicationPhase
Gene Therapy for PARKIN-PDParkinson's Disease (Parkin mutation-associated)Preclinical

Leadership Team at NysnoBio

JA
Jennifer A. Johnston, PhD
Cofounder and CEO
EH
Elizabeth Higgins, PhD
Chief Technology Officer
CG
Christina Gamba-Vitalo, PhD
Head of in vivo Pharmacology and Toxicology
RM
Ron Mandel, PhD
Head of Gene Therapy Programs
DG
David Giannini
Cofounder and Executive Chairman
View full NysnoBio profile